BIOPHARM
The computed 12-month bankruptcy probability of BIOPHARM is 1.3% (low). The company has been active since 1989 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 36 yrs |
| Board | 4 |
| Locations | 8 |
| Publications | 5 |
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 30-09-2025 | micro | 30-04-2026 | 2026-00103372 |
| 30-09-2024 | micro | 30-04-2025 | 2025-00086064 |
| 30-09-2023 | micro | 31-03-2024 | 2024-00057555 |
| 30-09-2022 | micro | 30-03-2023 | 2023-00055240 |
| 30-09-2021 | verkort | 13-04-2022 | 2022-20003843 |
| 30-09-2020 | verkort | 30-04-2021 | 2021-12900165 |
| 30-09-2019 | verkort | 14-05-2020 | 2020-12100594 |
| 30-09-2018 | verkort | 29-04-2019 | 2019-11700116 |
| 30-09-2017 | verkort | 18-05-2018 | 2018-13300309 |
| 30-09-2016 | verkort | 27-04-2017 | 2017-10400268 |
-
Current01-04-2019 → present
-
Current01-01-2018 → present
-
Current15-04-2013 → present
3 events
- 23-09-2024 Appointed· Director
- 01-04-2019 Mandate renewed· Director
- 15-04-2013 Mandate renewed· Director
-
Current15-04-2013 → present
3 events
- 23-09-2024 Appointed· Managing director
- 01-04-2019 Mandate renewed· Director
- 15-04-2013 Mandate renewed· Managing director
Former directors (2)
-
CaspiecaLegal entityDirector· perm. rep.: Ann Van de CasteeleState Gazette act 14052171 (27-02-2014)Former15-04-2013 → 23-09-2024
2 events
- 23-09-2024 Resigned· Director
- 15-04-2013 Mandate renewed· Director
-
I.L.T.-PHARMALegal entityDirector· perm. rep.: Kristel DielisState Gazette act 25133445 (21-10-2025)Former— → 23-09-2024
| NACE primary | Retail trade(47730) |
| Legal form | Public limited company(014) |
| Incorporation | 10-10-1989 |
| Status | Active |
| Postal code | 3070 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates — not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13023I0557/00G000 | Flanders | 2,750 m² | 1 · 702 m² | 6.7 m · 1 fl. |
| 24055B0162/00M003 | Flanders | 1,824 m² | 1 · 268 m² | 19.9 m · 3 fl. |
| 24066B0308/00N002 | Flanders | 1,803 m² | 1 · 132 m² | 9.8 m · 2 fl. |
| 13022E0070/00S000 | Flanders | 1,033 m² | 1 · 245 m² | 10.2 m · 2 fl. |
| 13032B0297/00H003 | Flanders | 662 m² | 1 · 217 m² | 10.3 m · 2 fl. |
| 24045C0049/00G000 | Flanders | 486 m² | 1 · 337 m² | 11.5 m · 2 fl. |
| 24592F0107/00X002indicative | Flanders | 346 m² | — | — |
| 24593G0388/00H000 | Flanders | 232 m² | 1 · 146 m² | 15.3 m · 4 fl. |
A single timeline of everything that happened to this company — publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
21-10-2025 2 directors appointed, 4 resigning
- Schrevens Theo — Gedelegeerd bestuurder
- Knapen Carine — Bestuurder
- V. Caspieca — Commissaris
- Ann Van de Casteele — Commissaris
- Kristel Dielis — Commissaris
- Tom Lauwerysen — Commissaris
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": "0860.588.255",
"name": "V. Caspieca",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-09-23",
"evidence_quote": "Bij beslissing van de algemene vergadering gehouden op 23/09/2024 werd het ontslag van: Comm. V. Caspieca (0860.588.255), met als vaste vertegenwoordiger Ann Van de Casteele, wonende te Engerstraat 67 in 3071 Erps-Kwerps, ILT-Pharma bv (0457.997.178), met als vaste vertegenwoordigers Kristel Dielis ",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Ann Van de Casteele",
"address": "Engerstraat 67 in 3071 Erps-Kwerps",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0457.997.178",
"name": "ILT-Pharma bv",
"address": null,
"country": null,
"legal_form": "bv"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-09-23",
"evidence_quote": "Bij beslissing van de algemene vergadering gehouden op 23/09/2024 werd het ontslag van: Comm. V. Caspieca (0860.588.255), met als vaste vertegenwoordiger Ann Van de Casteele, wonende te Engerstraat 67 in 3071 Erps-Kwerps, ILT-Pharma bv (0457.997.178), met als vaste vertegenwoordigers Kristel Dielis ",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Kristel Dielis",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0457.997.178",
"name": "ILT-Pharma bv",
"address": null,
"country": null,
"legal_form": "bv"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-09-23",
"evidence_quote": "Bij beslissing van de algemene vergadering gehouden op 23/09/2024 werd het ontslag van: Comm. V. Caspieca (0860.588.255), met als vaste vertegenwoordiger Ann Van de Casteele, wonende te Engerstraat 67 in 3071 Erps-Kwerps, ILT-Pharma bv (0457.997.178), met als vaste vertegenwoordigers Kristel Dielis ",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Tom Lauwerysen",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0457.997.178",
"name": "ILT-Pharma bv",
"address": null,
"country": null,
"legal_form": "bv"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-09-23",
"evidence_quote": "Bij beslissing van de algemene vergadering gehouden op 23/09/2024 werd het ontslag van: Comm. V. Caspieca (0860.588.255), met als vaste vertegenwoordiger Ann Van de Casteele, wonende te Engerstraat 67 in 3071 Erps-Kwerps, ILT-Pharma bv (0457.997.178), met als vaste vertegenwoordigers Kristel Dielis ",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "gedelegeerd bestuurder",
"person": {
"rrn": "551206-20974",
"name": "Schrevens Theo",
"address": "Vosken 13 te 3210 Lubbeek",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Het bestuursorgaan is vanaf die datum als volgt samengesteld: -Schrevens Theo (551206-20974), Vosken 13 te 3210 Lubbeek; gedelegeerd bestuurder",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": "560326-16063",
"name": "Knapen Carine",
"address": "Vosken 13 te 3210 Lubbeek",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Het bestuursorgaan is vanaf die datum als volgt samengesteld: -Schrevens Theo (551206-20974), Vosken 13 te 3210 Lubbeek; gedelegeerd bestuurder -Knapen Carine (560326-16063), Vosken 13 te 3210 Lubbeek, bestuurder",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Leuven",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-10-21",
"filing_date": "2025-10-10",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2024-09-23",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0438.547.292",
"name_full": "Biopharm",
"legal_form": "nv"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}21-10-2025 2 directors appointed, 2 resigning
- Schrevens Theo — Gedelegeerd bestuurder
- Knapen Carine — Bestuurder
- Ann Van de Casteele — Bestuurder
- Kristel Dielis — Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ann Van de Casteele",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0860588255",
"name": "Comm. V. Caspieca",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-09-23",
"evidence_quote": "Bij beslissing van de algemene vergadering gehouden op 23/09/2024 werd het ontslag van: Comm. V. Caspieca (0860.588.255), met als vaste vertegenwoordiger Ann Van de Casteele, wonende te Engerstraat 67 in 3071 Erps-Kwerps, ILT-Pharma bv (0457.997.178), met als vaste vertegenwoordigers Kristel Dielis "
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Kristel Dielis",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0457997178",
"name": "ILT-Pharma bv",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-09-23",
"evidence_quote": "Bij beslissing van de algemene vergadering gehouden op 23/09/2024 werd het ontslag van: Comm. V. Caspieca (0860.588.255), met als vaste vertegenwoordiger Ann Van de Casteele, wonende te Engerstraat 67 in 3071 Erps-Kwerps, ILT-Pharma bv (0457.997.178), met als vaste vertegenwoordigers Kristel Dielis "
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Schrevens Theo",
"address": null,
"birth_date": null
},
"effective_date": "2024-09-23",
"evidence_quote": "Het bestuursorgaan is vanaf die datum als volgt samengesteld: -Schrevens Theo (551206-20974), Vosken 13 te 3210 Lubbeek; gedelegeerd bestuurder"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Knapen Carine",
"address": null,
"birth_date": null
},
"effective_date": "2024-09-23",
"evidence_quote": "Het bestuursorgaan is vanaf die datum als volgt samengesteld: -Schrevens Theo (551206-20974), Vosken 13 te 3210 Lubbeek; gedelegeerd bestuurder -Knapen Carine (560326-16063), Vosken 13 te 3210 Lubbeek, bestuurder"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0438.547.292",
"name_full": "BIOPHARM",
"legal_form": "NV"
}
}10-12-2019 2 directors appointed, 1 resigning, 3 reappointed
- ILT Pharma bvba — Bestuurder
- Sophie Schrevens — Bestuurder
- CVA Schrevens-Beheer — Bestuurder
- Theo Schrevens — Bestuurder
- Carine Knapen — Bestuurder
- Caspieca GCV — Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "ILT Pharma bvba",
"address": null,
"birth_date": null
},
"effective_date": "2018-05-01",
"evidence_quote": "de vennootschap ILT Pharma bvba (0457.997.178) te benoemen tot bestuurder, met ingang vanaf 01/05/2018."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sophie Schrevens",
"address": null,
"birth_date": null
},
"effective_date": "2018-01-01",
"evidence_quote": "Sophie Schrevens (930420-43078) te benoemen als bestuurder vanaf 01/01/2018."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Theo Schrevens",
"address": null,
"birth_date": null
},
"effective_date": "2019-04-01",
"evidence_quote": "het mandaat van de andere bestuurders (Theo Schrevens - Carine Knapen en Caspieca GCV) te verlengen voor 6 jaren, vanaf heden."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Carine Knapen",
"address": null,
"birth_date": null
},
"effective_date": "2019-04-01",
"evidence_quote": "het mandaat van de andere bestuurders (Theo Schrevens - Carine Knapen en Caspieca GCV) te verlengen voor 6 jaren, vanaf heden."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Caspieca GCV",
"address": null,
"birth_date": null
},
"effective_date": "2019-04-01",
"evidence_quote": "het mandaat van de andere bestuurders (Theo Schrevens - Carine Knapen en Caspieca GCV) te verlengen voor 6 jaren, vanaf heden."
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "CVA Schrevens-Beheer",
"address": null,
"birth_date": null
},
"effective_date": "2019-04-01",
"evidence_quote": "CVA Schrevens-Beheer (0444.719.957) wordt ontslagen als bestuurder, vanaf heden (01/04/2019)."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0438.547.292",
"name_full": "BIOPHARM",
"legal_form": "NV"
}
}04-02-2019 Capital increase of €3,327,400 to €3,451,400
- €124.000 → €3.451.400
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 3327400.0,
"currency": "EUR",
"after_eur": 3451400.0,
"delta_eur": 3327400.0,
"before_eur": 124000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2018-09-26",
"evidence_quote": "Verhoging van het kapitaal met DRIE MILJOEN DRIEHONDERDZEVENENTWINTIGDUIZEND VIERHONDERD EURO (\u20AC 3.327.400,00) door inbreng in natura ... om het te brengen van honderdvierentwintigduizend euro (\u20AC 124.000,00) op drie miljoen vierhonderdeenenvijftigduizend vierhonderd euro (\u20AC 3.451.400,00)",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0438.547.292",
"name_full": "BIOPHARM",
"legal_form": "NV"
}
}27-02-2014 3 reappointed
- Theo Schrevens — Gedelegeerd bestuurder
- Carine Knapen — Bestuurder
- Van De Casteele A. — Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Theo Schrevens",
"address": null,
"birth_date": null
},
"effective_date": "2013-04-15",
"evidence_quote": "De raad van bestuur heeft besloten de volgende bestuurders te benoemen voor een termijn van zes jaar en dit vanaf 15 april 2013, met stilzwijgende vernieuwing vanaf de vervaldag."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Carine Knapen",
"address": null,
"birth_date": null
},
"effective_date": "2013-04-15",
"evidence_quote": "De raad van bestuur heeft besloten de volgende bestuurders te benoemen voor een termijn van zes jaar en dit vanaf 15 april 2013, met stilzwijgende vernieuwing vanaf de vervaldag."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Van De Casteele A.",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0860588255",
"name": "Caspieca GCV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2013-04-15",
"evidence_quote": "De raad van bestuur heeft besloten de volgende bestuurders te benoemen voor een termijn van zes jaar en dit vanaf 15 april 2013, met stilzwijgende vernieuwing vanaf de vervaldag."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0438.547.292",
"name_full": "BIOPHARM",
"legal_form": "NV"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | BIOPHARM |